These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26510488)

  • 1. Intravenous Immunoglobulin G Improves Pregnancy Outcome in Women with Recurrent Pregnancy Losses with Cellular Immune Abnormalities.
    Lee SK; Kim JY; Han AR; Hur SE; Kim CJ; Kim TH; Cho BR; Han JW; Han SG; Na BJ; Kwak-Kim J
    Am J Reprod Immunol; 2016 Jan; 75(1):59-68. PubMed ID: 26510488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL).
    Ahmadi M; Abdolmohammadi-Vahid S; Ghaebi M; Aghebati-Maleki L; Afkham A; Danaii S; Abdollahi-Fard S; Heidari L; Jadidi-Niaragh F; Younesi V; Nouri M; Yousefi M
    Biomed Pharmacother; 2017 Aug; 92():1095-1102. PubMed ID: 28622710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity.
    Ota K; Dambaeva S; Han AR; Beaman K; Gilman-Sachs A; Kwak-Kim J
    Hum Reprod; 2014 Feb; 29(2):208-19. PubMed ID: 24277747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a Role of Intravenous Immunoglobulin in Immunologic Recurrent Pregnancy Loss?
    Yang X; Meng T
    J Immunol Res; 2020; 2020():6672865. PubMed ID: 33426092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells.
    Moraru M; Carbone J; Alecsandru D; Castillo-Rama M; García-Segovia A; Gil J; Alonso B; Aguarón A; Ramos-Medina R; Martínez de María J; Oliver-Miñarro D; Rodríguez-Mahou M; Ortega V; Caballero P; Meliá E; Vidal J; Cianchetta-Sivori M; Esteban C; Vargas-Henny L; Dale J; Ortiz-Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2012 Jul; 68(1):75-84. PubMed ID: 22509929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of clinical cellular immune markers in women with recurrent pregnancy loss.
    Lee SK; Na BJ; Kim JY; Hur SE; Lee M; Gilman-Sachs A; Kwak-Kim J
    Am J Reprod Immunol; 2013 Nov; 70(5):398-411. PubMed ID: 23656517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin.
    Stricker RB; Steinleitner A; Bookoff CN; Weckstein LN; Winger EE
    Fertil Steril; 2000 Mar; 73(3):536-40. PubMed ID: 10689009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin G modulates peripheral blood Th17 and Foxp3(+) regulatory T cells in pregnant women with recurrent pregnancy loss.
    Kim DJ; Lee SK; Kim JY; Na BJ; Hur SE; Lee M; Kwak-Kim J
    Am J Reprod Immunol; 2014 May; 71(5):441-50. PubMed ID: 24645850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous immunoglobulin (IVIG) as treatment for recurrent pregnancy loss (RPL)].
    Sapir T; Carp H; Shoenfeld Y
    Harefuah; 2005 Jun; 144(6):415-20, 454, 453. PubMed ID: 15999561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
    Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
    J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion.
    Winger EE; Reed JL
    Am J Reprod Immunol; 2008 Jul; 60(1):8-16. PubMed ID: 18422811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions.
    Kwak JY; Kwak FM; Ainbinder SW; Ruiz AM; Beer AE
    Am J Reprod Immunol; 1996 Apr; 35(4):363-9. PubMed ID: 8739455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does immunotherapy for treatment of reproductive failure enhance live births?
    Coulam CB; Acacio B
    Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin (IVIG) treatment modulates peripheral blood Th17 and regulatory T cells in recurrent miscarriage patients: Non randomized, open-label clinical trial.
    Ahmadi M; Aghdam SA; Nouri M; Babaloo Z; Farzadi L; Ghasemzadeh A; Hamdi K; Movassaghpour AA; Jadidi-Niaragh F; Afkham A; Motallebnezhad M; Eghbal-Fard S; Dolati S; Younesi V; Yousefi M
    Immunol Lett; 2017 Dec; 192():12-19. PubMed ID: 29030251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin use in patients with unexplained recurrent pregnancy loss.
    Banjar S; Kadour E; Khoudja R; Ton-Leclerc S; Beauchamp C; Beltempo M; Dahan MH; Gold P; Jacques Kadoch I; Jamal W; Laskin C; Mahutte N; Reinblatt SL; Sylvestre C; Buckett W; Genest G
    Am J Reprod Immunol; 2023 Aug; 90(2):e13737. PubMed ID: 37491929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on treatment of immunologic abortion with low-dose intravenous immunoglobulin.
    Stricker RB; Winger EE
    Am J Reprod Immunol; 2005 Dec; 54(6):390-6. PubMed ID: 16305665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion.
    Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
    Am J Reprod Immunol; 1996 Apr; 35(4):370-5. PubMed ID: 8739456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin G treatment increases live birth rate in women with recurrent miscarriage and modulates regulatory and exhausted regulatory T cells frequency and function.
    Jafarzadeh S; Ahmadi M; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Kamrani A; Behrad B; Roshangar L; Jadidi-Niaragh F; Yousefi B; Mehdipour M; Farzadi L; Yousefi M
    J Cell Biochem; 2019 Apr; 120(4):5424-5434. PubMed ID: 30326143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion.
    Ramos-Medina R; García-Segovia A; Gil J; Carbone J; Aguarón de la Cruz A; Seyfferth A; Alonso B; Alonso J; León JA; Alecsandru D; Meliá E; Carrillo de Albornoz E; Ordoñez D; Santillán I; Verdú V; Garcia Ruiz de Morales JM; López-Hoyos M; López Larios A; Sampalo A; Caballero P; Ortiz Quintana L; Fernández-Cruz E; Sánchez-Ramón S
    Am J Reprod Immunol; 2014 May; 71(5):458-66. PubMed ID: 24612159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunotherapy as an effective treatment of recurrent spontaneous abortion--own experience].
    Jerzak M; Rechberger T; Baranowski W; Semczuk M
    Ginekol Pol; 2003 Oct; 74(10):1107-11. PubMed ID: 14669403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.